New data shows that ACC and similar cancers could be treated with already available drugs.
Researchers are following up their current study with further development of the targeted small molecule they recently discovered.
UnitedHealth hiked its 2016 forecast after the nation's largest health insurer topped Wall Street's first-quarter earnings expectations.
Using a mouse model for pulmonary alveolar proteinosis, the authors demonstrate that this rare disease can be cured by a single transfer of monocytes.
Since its introduction in February 2015, more than 25,000 women have been prescribed IBRANCE by more than 6,000 prescribers in the U.S.
Antibiotic-resistant infections are a growing threat to public health.
Identifying NS1 also helps to diagnose infections, and other research teams are eyeing it as a possible target for antiviral drug development.
Precision medicine's public face is that of disease -- and better treatments for that disease through targeted therapies. But precision medicine has an unsung partner that could affect the lives of many more people: Precision prevention.
Transplants of insulin-producing pancreas cells are a long hoped-for treatment for diabetes - and a new study shows they can protect the most seriously ill patients from a life-threatening complication of the disease, an important step toward U.S. approval.
The sources of the opioid epidemic are complex, but one powerful motivator has been the pursuit of profit.
Key to this process is Relaxin’s ability to break down collagen.
More research will be required to show safety and efficacy in humans.
Blocking the hormone that raises sugar levels in the blood could increase insulin levels while keeping blood sugar levels down.
The controlled release of calcium is a key step in many cellular processes.
Immuno-oncology products have demonstrated comparable respective efficacy and safety profiles.